This significant role in immunosuppression can be at least partially mediated by FasL, suggesting that both FasL expressed on GBM cells (by cell–cell contact) and FasL expressed on GBM-derived EVs inhibit T-cell functions (151). The gene discussed is FASLG; the disease is glioblastoma.